Cov ntaub ntawv khoom
Lub npe:Huperzine A
CAS Nr:.102518-79-6
Cov mis mos molecular:C15H18N2O
Molecular qauv:
Specification:≥98%
Kev kuaj xyuas txoj kev:HPLC
Xim:yellowish crystalline hmoov
Pharmacological teebmeem ntawm huperzine A
Huperzine A yog ib qho zoo heev reversible cholinesterase inhibitor nrog muaj zog cholinergic kev ua si.Nws yog Ameslikas siv los kho myasthenia gravis.Tom qab soj ntsuam, nws muaj ib tug tseem ceeb nco pab txhawb cov neeg laus nrog benign nco impairment thiab muaj peev xwm txhim kho kev nco thiab kev txawj ntse functions.Pharmacological Cov kev sim pom tau tias huperzine A muaj zog cholinergic kev ua si thiab thim rov qab xaiv inhibition ntawm qhov tseeb cholinesterase.Nws tuaj yeem pab txhawb kev sib kis ntawm cov neurotransmitters ntawm neuromuscular junction.Nws tuaj yeem nce qib ntawm acetylcholine, txhawb kev nco rov qab thiab txhim kho kev nco.
Tes muaj peev xwm
Nrog cov khoom muag, ntau lawm tuaj yeem nthuav dav lossis kho.
Hande ntau lawm zoo
Hande, uas tau tsim nws tus kheej GMP ntau lawm puag, tau dhau los ntawm kev tshuaj xyuas cov cai thiab cov cai ntawm FDA, EDQM, GMP hauv Suav teb, PMDA hauv Nyij Pooj, TGA hauv Australia, Kaus Lim Qab Teb, Is Nrias teb, Taiwan, Tuam Tshoj, Türkiye, Russia, SGS , Dun & Bradley, thiab lwm yam Nyob rau tib lub sijhawm, lub tuam txhab tau nruab nrog pab pawg tshawb fawb thiab kev tsim kho thiab tau ua tiav tau ntau yam patents.QC chav kuaj, ua kom paub txog cov khoom lag luam kuaj qhov project.
Peb Cov Kev Pabcuam
1.Cov khoom:Muab cov khoom zoo, siab dawb huv cog rho tawm, cov khoom siv tshuaj, thiab cov tshuaj intermediates.
2.Kev pab cuam:Customized extracts nrog tshwj xeeb specifications raws li tus neeg yuav tsum tau muaj.
Ua tus xa khoom zoo tshaj plaws ntawm cov khoom siv raw thiab cov lag luam nrog kev ncaj ncees!
Zoo siab txais tos hu rau kuv los ntawm email raumarketing@handebio.com